By using www.3bfuturehealth.com website you agree to our use of cookies to enhance your experience.
We have updated our Terms of Use, Privacy & Cookies Policies in October 2022. To review them please follow the links below
Terms of Use | Privacy and Cookies Policy
23 November 2021
FDA approves sirolimus protein-bound particles for malignant perivascular epithelioid cell tumor
Aadi Bioscience Announces FDA Approval of its First Product FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)
26 August 2021
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
17 May 2021
Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive Merger Agreement
8 May 2017
HELSINN INVESTMENT FUND INVESTS IN AADI BIOSCIENCE
Thank you for your form submission, we will get in contact with you shortly.